Q84TA3
Gene name |
LKHA4 (Os03g0819100, LOC_Os03g60460, OJ1754_E06.9, OsJ_13129) |
Protein name |
Leucine aminopeptidase |
Names |
Epoxide hydrolase, Leukotriene A-4 hydrolase homolog, LTA-4 hydrolase |
Species |
Oryza sativa subsp japonica (Rice) |
KEGG Pathway |
osa:4334583 |
EC number |
3.3.2.10: Ether hydrolases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q84TA3
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q84TA3-F1 | Predicted | AlphaFoldDB |
No variants for Q84TA3
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q84TA3 | |||||
No associated diseases with Q84TA3
3 regional properties for Q84TA3
Functions
| Description | ||
|---|---|---|
| EC Number | 3.3.2.10 | Ether hydrolases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| epoxide hydrolase activity | Catalysis of the reaction: an epoxide + H2O = a glycol. |
| metallopeptidase activity | Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions. |
| zinc ion binding | Binding to a zinc ion (Zn). |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| leukotriene biosynthetic process | The chemical reactions and pathways resulting in the formation of leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid. |
| proteolysis | The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MPPVDPHSYT | DGDHPVTAKA | ALAFYLDFAA | STIHASALLT | LSAPHSGDLL | LDTRALAVHS |
| 70 | 80 | 90 | 100 | 110 | 120 |
| ASTASGPPSP | IPFSLADAAD | PVLGSALTLT | LPPDTTSFLL | TFSTSPSASA | LQWLSPPQTA |
| 130 | 140 | 150 | 160 | 170 | 180 |
| SSLPFVFSQC | QSIHARSVFP | CHDTPAARIT | FDLLLNVPTQ | LSAVAAARHV | SRRDPLPSDH |
| 190 | 200 | 210 | 220 | 230 | 240 |
| RGACDDALWC | APGRIVEEFQ | MEQSVPPYLF | AFAAGGIGFR | DLGPRTRVYA | EGGDKVLDEA |
| 250 | 260 | 270 | 280 | 290 | 300 |
| AREFAGVEEM | VKVGESLFGP | YEWERFDLLV | LPPSFPYGGM | ENPRMVFLTP | TVIKGDAAGA |
| 310 | 320 | 330 | 340 | 350 | 360 |
| QVVAHELAHS | WTGNLITNKT | NEDFWLNEGF | TTYAERRIVE | VVQGEERAAL | NMGIGWRGLN |
| 370 | 380 | 390 | 400 | 410 | 420 |
| RMMERFKDNM | EYTKLKPKMA | GIDPDDVYSE | VPYEKGFQFL | WRIERQIGRP | AFDEFLKNYI |
| 430 | 440 | 450 | 460 | 470 | 480 |
| STFKFKSIDT | ETFLEFLKTN | VPGIENQIDL | QLWIEGTGIP | PDAMEPESAI | YKKICSLAAE |
| 490 | 500 | 510 | 520 | 530 | 540 |
| FKSGKLPSED | EVADWSGQEW | ELYLENLPTD | VEASQVTALD | ERYKLSESCD | YEVKVAFLQL |
| 550 | 560 | 570 | 580 | 590 | 600 |
| AIPTGCRCYF | NEVEKCLKQV | GRMKYLRPLY | SSLARCSGEE | KMLAHRIFSE | AHEFYHPIAR |
| 610 | |||||
| SVAESILSKH | G |